Skip to main content

Study

Melatonin: A Potential Aid in Preventing Delirium for Seniors

Melatonin might help reduce delirium in hospitalized seniors.

Brain HealthSleepHealthy Aging
Study Credibility: High9.1/10From a trusted journalProperly designed studyResults verified
PublishedJan 2026DesignRCTLast reviewedMar 2026
Email this

Summary

In plain language

This study looked at whether taking melatonin can help prevent delirium in seniors who are hospitalized. Delirium is a state of confusion that often affects older adults in hospitals, making recovery more challenging. Researchers found that melatonin, a natural hormone that helps regulate sleep, could potentially reduce the chances of developing delirium. While the study faced some challenges, such as early termination and a lower occurrence of delirium than expected, the findings suggest that melatonin could be a simple and safe option to discuss with your doctor if you're hospitalized.

Details

Use the full description to understand the study design, methods, and the limits of the findings.

This study was conducted in a hospital setting, focusing on patients aged 65 and older. Researchers randomly assigned seniors to receive either melatonin or a placebo to see if melatonin could prevent delirium.

  • Participants took 5 mg or 8 mg of melatonin, or a placebo, each night for up to 5 days.
  • Results showed a potential reduction in delirium, though the study ended early, making conclusions less certain.
  • Melatonin is generally well-tolerated, but the study faced limitations like a smaller-than-planned sample size.

If you're concerned about delirium during hospital stays, consider discussing melatonin with your healthcare provider.

Research Quality Score

Scored March 13, 2026 using rubric v8_2026-03-10.

Assessment

This study is a high-quality RCT with strong design and methodology, making it a reliable source of evidence for the use of melatonin in preventing delirium in seniors. Despite some limitations in statistical power due to early termination, the study's transparency and relevance to the senior population are commendable.

Category Breakdown

CategoryScoreRating
Study design10.0/10
Bias control8.3/10
Statistical methods7.5/10
Reporting completeness10.0/10
Conflicts & funding10.0/10
Replication5.0/10
Relevance to chosen population10.0/10
Journal Reliability10.0/10

Additional Notes

The study's early termination and lower-than-expected delirium incidence are notable limitations, but the overall methodological quality remains strong.

Take the next step

Build a personalized plan using research-backed studies, conditions, and treatments.